ERBB2 and neoplasm: It was observed that more radium-223 activity was detected in tumors treated with HER2-TTC in comparison to the radiolabeled isotype control, manifesting the specificity of HER2-TTC, although the determined activity of radium-223 was lower than theoretical calculated if all activity from decaying thorium-227 was maintained in the tumor.